Global Glioblastoma Multiforme Treatment Market to Reach USD 4.1 Billion by 2033, Propelled by Rising Incidence of Glioblastoma Multiforme

January 03, 2025 | Healthcare

VIEW FULL TABLE OF CONTENTS

According to the latest report by IMARC Group, titled “Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2025-2033," the global glioblastoma multiforme treatment market size reached USD 2.3 Billion in 2024. Glioblastoma multiforme (GBM) refers to an aggressive and malignant brain tumor that arises from the supportive tissues of the brain. Its symptoms include nausea, headache, vomiting, seizures, weakness, difficulty speaking, cognitive decline, personality changes, and motor deficits. It is diagnosed through neurological examinations, cognitive assessments, biopsy, and various imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT) scans. GBM treatment involves medications, surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. These treatments prevent tumor growth, kill cancer cells, slow disease progression, stimulate the immune system, and alleviate various symptoms. They also aid in improving clinical outcomes, increasing survival rates, regaining lost motor functions, and enhancing patients’ quality of life.

Global Glioblastoma Multiforme Treatment Market Trends:

The rising incidence of GBM due to inherited genetic conditions, radiation exposure, and environmental factors is one of the primary factors creating a positive outlook for the market. GBM treatments are widely used to slow down the progression of the disease, prevent tumor growth, kill cancer cells, increase patients’ survival rate, and manage various symptoms, such as headaches, seizures, and neurological deficits. Furthermore, the increasing awareness among the masses regarding early diagnosis and treatment of GBM to improve clinical outcomes, prevent future complications, reduce healthcare expenditure, and enhance patients’ quality of life is providing an impetus to the market growth. Additionally, the recent development of tumor treating fields (TTF) therapy, which is a non-invasive treatment that utilizes electrical fields to disrupt cell division and slow down cancer progression, is positively influencing the market growth. Apart from this, the integration of artificial intelligence (AI)-based algorithms to improve the accuracy of diagnosis, identify the best treatment plan, predict patient outcomes, and aid clinicians in making informed decisions is providing a thrust to the market growth. Moreover, the implementation of various government initiatives to improve healthcare infrastructure and provide access to high-quality treatment options is facilitating the market growth. Other factors, including rising healthcare expenditure, increasing investment in the research and development (R&D) of advanced treatments, and the growing numbers of drug approval, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach USD 4.1 Billion by 2033, exhibiting a CAGR of 6.39% during 2025-2033.

Market Summary:

On the basis of the drug type, the market has been divided into temozolomide, bevacizumab, carmustine, radiosensitizer, and others.
Based on the route of administration, the market has been bifurcated into oral and parenteral.
On the basis of the type of molecule, the market has been classified into small molecule and biologics.
Based on the distribution channel, the market has been divided into hospitals, pharmacies, and others.
On a regional basis, the market has been categorized into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the industry has also been examined, with some of the key players being Sun Pharmaceutical Industries, Celldex Therapeutics, Pfizer, F. Hoffmann La Roche, Bristol-Myers Squibb, Teva Pharmaceuticals, Exelixis, Angiochem and Arbor Pharmaceuticals.

Report Scope:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Billion USD
Segment Coverage	Drug Type, Route of Administration, Type of Molecule, Distribution Channel, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered	Sun Pharmaceutical Industries, Celldex Therapeutics, Pfizer, F. Hoffmann La Roche, Bristol-Myers Squibb, Teva Pharmaceuticals, Exelixis, Angiochem and Arbor Pharmaceuticals
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Glioblastoma Multiforme Treatment Market to Reach USD 4.1 Billion by 2033, Propelled by Rising Incidence of Glioblastoma Multiforme

Purchase Options Discount
Offer

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.